Photo: Getty Images
(Undated) -- Pfizer and BioNTech ask the U.S. Food and Drug Administration emergency use authorization for their COVID-19 vaccine for kids ages 5 to 11-years-old. New York Times reports the FDA says it has tentatively scheduled a meeting on October 26th, 2021 to consider the request. A ruling is expected between Halloween and Thanksgiving.